INDIANAPOLIS, Jan. 20, 2026 /PRNewswire/ -- Eli Lilly and Company (LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to sofetabart ...
Indianapolis-based drug giant Eli Lilly and Co. on Monday announced an agreement to acquire cancer-drug developer Ajax Therapeutics Inc. in a deal worth up to $2.3 billion. The acquisition is the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results